Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer

被引：0

作者：

AW Partin

MK Brawer

ENP Subong

CA Kelley

JL Cox

DJ Bruzek

J Pannek

GE Meyer

DW Chan

机构：

[1] The Brady Urological Institute,Department of Urology

[2] The Johns Hopkins Hospital,Department of Pathology

[3] The Brady Urological Institute,undefined

[4] The Johns Hopkins Hospital,undefined

[5] The University of Washington and Seattle Veterans Affairs Administration Medical Center,undefined

来源：

Prostate Cancer and Prostatic Diseases | 1998年 / 1卷

关键词：

prostate cancer; detection; percent ; -PSA; complexed-PSA; prospective;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Aims of the study: Retrospective studies investigating the use of percent free-PSA for early detection of prostate cancer were limited for various reasons: by their use of long-term stored sera, poor mix of non-cancer to cancer cases and the use of only men with PSA values between 4.0 and 10.0 ng/mL. This prospective study investigates the clinical utility of percent free-PSA and complexed-PSA for early detection of prostate cancer in 219 consecutive men presenting for prostate biopsy.

引用

页码：197 / 203

页数：6

共 50 条

[21] The behavior of prostate specific antigen (PSA) and free-PSA (f-PSA) under antihormonal therapy
Wechsel, HW
Gleichmann, R
Blasseneck, J
ANTICANCER RESEARCH, 2000, 20 (6D) : 4993 - 4994
[22] Prostate cancer probability after total PSA and percent free PSA determination
Mione, R
Barioli, P
Barichello, M
Zattoni, F
Prayer-Galetti, T
Plebani, M
Aimo, G
Terrone, C
Manferrari, F
Madeddu, G
Caberlotto, L
Fandella, A
Pianon, C
Vianello, L
Gion, M
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1998, 13 (02): : 77 - 86
[23] [-2]PROPSA IN COMBINATION WITH PSA AND FREE-PSA, USING THE BECKMAN COULTER ACCESS IMMUNOASSAY SYSTEMS IMPROVES PROSTATE CANCER DETECTION RELATIVE TO PSA AND FREE PSA. A MULTI-CENTER PROSPECTIVE CLINICAL STUDY.
Catalona, William J.
Sanda, Martin G.
Wei, John T.
Klee, George G.
Slawin, Kevin M.
Marks, Leondard S.
Bangma, Chris H.
Chan, Daniel W.
Sokoll, Lori J.
Roberts, William L.
van Schaik, Ron
Broyles, Dennis L.
Cruz, Amabelle B.
Mizrahi, Isaac A.
Shin, Sanghyuk S.
Partin, Alan W.
JOURNAL OF UROLOGY, 2010, 183 (04): : E717 - E717
[24] Comparison of prostate specific antigen (PSA) density of the transition zone with percent free PSA and other PSA indexes in the detection of prostate cancer.
Kamoi, K
Troncoso, P
Ramirez, EI
Babaian, RJ
JOURNAL OF UROLOGY, 1998, 159 (05): : 235 - 235
[25] Cost-benefit analysis of total PSA, free/total PSA and complexed PSA for prostate cancer screening
Ellison, L
Bright, S
Veltri, R
Cheli, C
Partin, A
JOURNAL OF UROLOGY, 2002, 167 (04): : 11 - 12
[26] Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age
Sävblom, C
Malm, J
Giwercman, A
Nilsson, JÅ
Berglund, G
Lilja, H
PROSTATE, 2005, 65 (01): : 66 - 72
[27] Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation
Bunting, PS
DeBoer, G
Choo, R
Danjoux, C
Klotz, L
Fleshner, N
CLINICAL BIOCHEMISTRY, 2002, 35 (06) : 471 - 475
[28] Clinical usefulness of free PSA in early detection of prostate cancer
Luboldt, HJ
Swoboda, A
Börgermann, C
Fornara, P
Rübben, H
ONKOLOGIE, 2001, 24 (01): : 33 - 37
[29] Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total PSA, prostate volume, and age
Partin, AW
Catalona, WJ
Southwick, PC
Subong, ENP
Gasior, GH
Chan, DW
UROLOGY, 1996, 48 (6A) : 55 - 61
[30] International multi-center comparison of complexed prostate specific antigen (CPSA) with total PSA, percent cpsa, and percent free PSA
Trock, B
Miller, MC
Cheli, CD
Brower, MK
Filella, X
Mitchell, IDC
Babaian, RJ
Partin, AW
JOURNAL OF UROLOGY, 2004, 171 (04): : 333 - 333

← 1 2 3 4 5 →